ESIDREX
As listed in the register: ESIDREX 25 mg, comprimé sécable
25 mg · comprimé sécable
- Prescription only
- Active substance
- Hydrochlorothiazide
- Made by
- LABORATOIRES JUVISE PHARMACEUTICALS
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (INZIRQO). It describes the substance, not this exact product.
Thiazides affect the renal tubular mechanisms of electrolyte reabsorption, directly increasing excretion of sodium and chloride in approximately equivalent amounts.
Indirectly, the diuretic action of hydrochlorothiazide reduces plasma volume, with consequent increases in plasma renin activity, increases in aldosterone secretion, increases in urinary potassium loss, and decreases in serum potassium.
At least 61% of the oral dose is eliminated unchanged in the urine within 24 hours.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2025-12-16
Safety of the active substance
From the US prescribing label for the same active substance (INZIRQO). It describes the substance, not this exact product.
- INZIRQO is contraindicated: In patients with anuria.
- In patients with hypersensitivity to hydrochlorothiazide or any ingredient in INZIRQO.
- In patients with hypersensitivity to sulfonamide-derived drugs.
- Anuria (4) Hypersensitivity to hydrochlorothiazide or any ingredient in INZIRQO (4) Hypersensitivity to sulfonamide-derived drugs (4)
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States31 matching products
Details
| Made by | LABORATOIRES JUVISE PHARMACEUTICALS |
|---|---|
| Active substance | Hydrochlorothiazide |
| Strength | 25 mg |
| Form | comprimé sécable |
| Route | orale |
| Dispensing (as stated by the register) | liste II |
| Marketed | Yes, according to the register |
| Authorisation procedure | Procédure nationale |
| Name in the register | ESIDREX 25 mg, comprimé sécable |
| Packs | plaquette(s) PVC polyéthylène PVDC aluminium de 30 comprimé(s) · plaquette(s) PVC polyéthylène PVDC aluminium de 90 comprimé(s) |
| CIS | 66153192 |
| CIP13 | 3400937196543 |
| CIP13 | 3400937196604 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.